Menon Krishna V, Al-Mukhtar Ahmed, Aldouri Amer, Prasad Rajendra K, Lodge Peter A, Toogood Giles J
HPB and Transplant Unit, St James's University Hospital, Leeds, United Kingdom.
J Am Coll Surg. 2006 Nov;203(5):677-83. doi: 10.1016/j.jamcollsurg.2006.07.025. Epub 2006 Sep 26.
We aimed to study the early and longterm outcomes of patients 70 years and older undergoing major liver resections, and compare the results with patients below the age of 70 years.
All patients undergoing major liver resection (defined as three segments or more) from January 1993 to June 2004 were included. Patients were studied in two groups: 70 years of age and older (group E, elderly) and less than 70 years old (group Y, young). Early outcomes and longterm survival were analyzed.
A total of 517 patients underwent major liver resection: group E, n=127; group Y, n=390 patients. There was no difference in operative mortality (group E, 7.9%; group Y, 5.4%; p=0.32) or postoperative morbidity (p=0.22) between the groups. Overall and disease-free survivals were not notably different for all patients (59% versus 57%, p=0.89; 60% versus 55%, p=0.28, respectively) or for a subgroup of patients with colorectal liver metastases (61% versus 55%, p=0.76; 60% versus 47%, p=0.07) in groups E versus Y, respectively. In multivariable analysis, American Society of Anesthesiologists grade 3 (p=0.024, hazard ratio [HR]=1.59, versus grade 1, 95% CI=1.06 to 2.39) and intraoperative transfusion>3 U (p<0.0005, HR=2.56, 95% CI=1.84 to 3.56) were predictors for overall survival. More than three tumors (p=0.025, HR=1.41, 95% CI=1.04 to 1.90) and redo resection (p=0.001, HR=2.80, 95% CI=1.51 to 5.19) were predictors of disease-free survival.
Major liver resections can be safely performed in patients 70 years of age or older, with early results and survival similar to those in the younger than 70 age group. American Society of Anesthesiologists grade 3 and intraoperative transfusions>3 U were predictors for overall survival, and more than three tumors and redo resection were predictors for disease-free survival.
我们旨在研究70岁及以上接受大肝切除术患者的早期和长期预后,并将结果与70岁以下患者进行比较。
纳入1993年1月至2004年6月期间所有接受大肝切除术(定义为切除三个或更多肝段)的患者。患者分为两组进行研究:70岁及以上(E组,老年组)和70岁以下(Y组,年轻组)。分析早期预后和长期生存率。
共有517例患者接受了大肝切除术:E组,n = 127;Y组,n = 390例患者。两组之间的手术死亡率(E组,7.9%;Y组,5.4%;p = 0.32)或术后发病率(p = 0.22)无差异。所有患者的总生存率和无病生存率无显著差异(分别为59%对57%,p = 0.89;60%对55%,p = 0.28),E组和Y组中结直肠癌肝转移患者亚组的总生存率和无病生存率也无显著差异(分别为61%对55%,p = 0.76;60%对47%,p = 0.07)。在多变量分析中,美国麻醉医师协会3级(p = 0.024,风险比[HR]=1.59,与1级相比,95%可信区间=1.06至2.39)和术中输血>3单位(p<0.0005,HR = 2.56,95%可信区间=1.84至3.56)是总生存的预测因素。肿瘤超过三个(p = 0.025,HR = 1.41,95%可信区间=1.04至1.90)和再次手术切除(p = 0.001,HR = 2.80,95%可信区间=1.51至5.19)是无病生存的预测因素。
70岁及以上患者可以安全地进行大肝切除术,早期结果和生存率与70岁以下年龄组相似。美国麻醉医师协会3级和术中输血>3单位是总生存的预测因素,肿瘤超过三个和再次手术切除是无病生存的预测因素。